These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 17971528

  • 21. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM.
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [Abstract] [Full Text] [Related]

  • 22. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [Abstract] [Full Text] [Related]

  • 23. Age considerations when vaccinating against HPV.
    Wright TC, Huh WK, Monk BJ, Smith JS, Ault K, Herzog TJ.
    Gynecol Oncol; 2008 May 19; 109(2 Suppl):S40-7. PubMed ID: 18482558
    [Abstract] [Full Text] [Related]

  • 24. [Human papilloma virus and cervical cancer].
    Berumen-Campos J.
    Gac Med Mex; 2006 May 19; 142 Suppl 2():51-9. PubMed ID: 19031679
    [Abstract] [Full Text] [Related]

  • 25. [Clearance, persistence and recurrence of HPV infection].
    Denis F, Hanz S, Alain S.
    Gynecol Obstet Fertil; 2008 Apr 19; 36(4):430-40. PubMed ID: 18417407
    [Abstract] [Full Text] [Related]

  • 26. Evidence sketchy on circumcision and cervical cancer link.
    Hill G.
    Can Fam Physician; 2003 Dec 19; 49():1591. PubMed ID: 14708919
    [No Abstract] [Full Text] [Related]

  • 27. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A, Lukic A, Nobili F, Palazzo A, Iacovelli R, French D, Moscarini M.
    Anticancer Res; 2007 Dec 19; 27(6C):4491-4. PubMed ID: 18214065
    [Abstract] [Full Text] [Related]

  • 28. HPV-linked malignancy and the potential of vaccine-based prevention.
    Laurence J.
    AIDS Read; 2005 Jan 19; 15(1):3-4. PubMed ID: 15685728
    [No Abstract] [Full Text] [Related]

  • 29. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM.
    Vaccine; 2008 Jan 10; 26(2):250-6. PubMed ID: 18068276
    [Abstract] [Full Text] [Related]

  • 30. Cervical cancer screening in the early post vaccine era.
    Waxman AG.
    Obstet Gynecol Clin North Am; 2008 Dec 10; 35(4):537-48; vii. PubMed ID: 19061815
    [Abstract] [Full Text] [Related]

  • 31. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [Abstract] [Full Text] [Related]

  • 32. The new era of cervical cancer prevention: HPV vaccination.
    Monk BJ, Herzog TJ.
    Gynecol Oncol; 2008 May 19; 109(2 Suppl):S1-3. PubMed ID: 18482553
    [No Abstract] [Full Text] [Related]

  • 33. Assessing the HPV vaccine: researchers confront complex interplay of factors.
    Tuma RS.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):444-5. PubMed ID: 19318636
    [No Abstract] [Full Text] [Related]

  • 34. The epidemiology behind the HPV vaccine discovery.
    Koutsky L.
    Ann Epidemiol; 2009 Apr 01; 19(4):239-44. PubMed ID: 19344861
    [Abstract] [Full Text] [Related]

  • 35. Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies.
    Panatto D, Amicizia D, Lugarini J, Sasso T, Sormani MP, Badolati G, Gasparini R.
    Vaccine; 2009 May 29; 27 Suppl 1():A6-10. PubMed ID: 19480964
    [Abstract] [Full Text] [Related]

  • 36. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
    Dillner L, Pagliusi S, Bray F, Lorincz A, Kjaer SK, Anttila A, Iversen OE, Dillner J, Lehtinen M, Paavonen J.
    Acta Obstet Gynecol Scand; 2008 May 29; 87(5):489-98. PubMed ID: 18446530
    [Abstract] [Full Text] [Related]

  • 37. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 38. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer.
    Vaccine; 2007 Nov 01; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract] [Full Text] [Related]

  • 39. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M, Smith A, Croy S, Lyons A, Ryall R, Garland S, Wong ML, Hseon TE.
    Vaccine; 2009 May 14; 27(22):2989-93. PubMed ID: 19428910
    [Abstract] [Full Text] [Related]

  • 40. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL.
    J Infect Dis; 2009 May 15; 199(10):1514-24. PubMed ID: 19392625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.